Sanne van Wissen
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Atherosclerosis and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial(2001)920 cited
- → Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors(2023)140 cited
- → Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy(2002)115 cited
- → Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy(2003)112 cited
- → Phenotypic variability in familial hypercholesterolaemia: an update(2002)96 cited
- → Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trial(2017)95 cited
- → The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia(2004)83 cited
- → Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, d-Dimer Testing, and Ultrasonography for Suspected Upper Extremity Deep Venous Thrombosis(2014)82 cited
- → Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia(2003)69 cited
- → Toll‐like receptor‐4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia(2004)66 cited